FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma

Figure 7 Visualisation of Gene Set Variation Analysis results. A: Complex heat map of gene sets showing differences (P < 0.05) between datasets The Cancer Genome Atlas (TCGA)-stomach adenocarcinoma (STAD) high and low risk subgroups (subgroup: High and subgroup: Low); B: Subgroup comparison map of gene sets showing differences (P < 0.05) between datasets TCGA-STAD high and low risk subgroups (subgroup: High and subgroup: Low); C: Comparison of gene sets showing differences (P < 0.05) between datasets TCGA-STAD high and low risk subgroups (subgroup: High and subgroup: Low). Up: Up-regulated genes; Down: Down-regulated genes. ¹P < 0.05, indicating statistical significance. ²P < 0.01, which is highly statistically significant. ³P < 0.001 and highly statistically significant.